Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05193916 |
|---|---|
| Brief Title: | A Phase II Clinical Trial of Chiglitazar for NASH |
| First Submitted : | December 3, 2021 |
| First Submitted that Met QC Criteria : | January 3, 2022 |
| First Posted : | January 18, 2022 |
| Last Update Submitted that Met QC Criteria : | August 24, 2023 |
| Last Update Posted : | August 28, 2023 |